作者：
Cumberbatch,M. [1]
;
Tang,X. [2]
;
Beran,G. [3]
;
Eckersley,S. [4]
;
Wang,X. [5]
;
Ellston,R.P.A. [6]
;
Dearden,S. ;
Cosulich,S. ;
Smith,P.D. ;
Behrens,C. ;
Kim,E.S. ;
Su,X. ;
Fan,S. ;
Gray,N. ;
Blowers,D.P. ;
Wistuba,I.I. ;
Womack,C.
作者单位：
AstraZeneca RandD, Oncology IMed, Mereside 33G83/197, Alderley Park, Macclesfield, Cheshire SK10
[1]
Former AstraZeneca, Macclesfield, Cheshire, United Kingdom
[2]
AstraZeneca, Asia and Emerging Markets IMed, Shanghai, China, Novartis Institutes for BioMedical
[3]
AstraZeneca, Asia and Emerging Markets IMed, Shanghai, China
[4]
Thoracic/Head and Neck Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston
[5]
Departments of Translational Molecular Pathology, University of Texas, MD Anderson Cancer Center
[6]
发布时间
2014-04-03
换一批
